-
V.
Mootha,
C.
Lindgren,
K.
Eriksson,
A.
Subramanian,
S.
Sihag,
J.
Lehár,
P.
Puigserver,
E.
Carlsson,
M.
Ridderstråle,
E.
Laurila,
N.
Houstis,
M.
Daly,
N.
Patterson,
J.
Mesirov,
T.
Golub,
P.
Tamayo,
B.
Spiegelman,
E.
Lander,
J.
Hirschhorn,
D.
Altshuler,
L.
Groop
(2003)
PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes
Nature Genetics, 34
-
D.
Byun,
K.
Chae,
B.
Ryu,
Min-Goo
Lee,
S.
Chi
(2002)
Expression and mutation analyses of P53R2, a newly identified p53 target for DNA repair in human gastric carcinoma
International Journal of Cancer, 98
-
J.
Hundley,
S.
Koester,
D.
Troyer,
S.
Hilsenbeck,
M.
Subler,
J.
Windle
(1997)
Increased tumor proliferation and genomic instability without decreased apoptosis in MMTV-ras mice deficient in p53
Molecular and Cellular Biology, 17
-
Y.
Engstrom,
Staffan
Eriksson,
Ingalill
Jildevik,
Sven
SkogS,
L.
Thelander,
Bernard
TribukaitS
(1985)
Cell cycle-dependent expression of mammalian ribonucleotide reductase. Differential regulation of the two subunits.
The Journal of biological chemistry, 260 16
-
Xiyong
Liu,
Bingsen
Zhou,
Lijun
Xue,
F.
Yen,
P.
Chu,
F.
Un,
Y.
Yen
(2007)
Ribonucleotide reductase subunits M2 and p53R2 are potential biomarkers for metastasis of colon cancer.
Clinical colorectal cancer, 6 5
-
H.
Okumura,
S.
Natsugoe,
N.
Yokomakura,
Y.
Kita,
M.
Matsumoto,
Y.
Uchikado,
T.
Setoyama,
T.
Owaki,
S.
Ishigami,
T.
Aikou
(2006)
Expression of p53R2 Is Related to Prognosis in Patients with Esophageal Squamous Cell Carcinoma
Clinical Cancer Research, 12
-
Lufen
Chang,
Bingsen
Zhou,
Shuya
Hu,
R.
Guo,
Xiyong
Liu,
S.
Jones,
Y.
Yen
(2008)
ATM-mediated serine 72 phosphorylation stabilizes ribonucleotide reductase small subunit p53R2 protein against MDM2 to DNA damage
Proceedings of the National Academy of Sciences, 105
-
J.
Klaunig,
L.
Kamendulis
(2004)
The role of oxidative stress in carcinogenesis.
Annual review of pharmacology and toxicology, 44
-
S.
Yanamoto,
G.
Kawasaki,
I.
Yoshitomi,
A.
Mizuno
(2003)
Expression of p53R2, newly p53 target in oral normal epithelium, epithelial dysplasia and squamous cell carcinoma.
Cancer letters, 190 2
-
(2006)
p53 inducible ribonucleotide reductase gene, correlated with tumor progression of non-small cell lung cancer
-
Keqiang
Zhang,
Shuya
Hu,
Jun
Wu,
Linling
Chen,
Jianming
Lu,
Xiaochen
Wang,
Xiyong
Liu,
Bingsen
Zhou,
Y.
Yen
(2009)
Overexpression of RRM2 decreases thrombspondin-1 and increases VEGF production in human cancer cells in vitro and in vivo: implication of RRM2 in angiogenesis
Molecular Cancer, 8
-
(2006)
Metastasissuppressing potential of ribonucleotide reductase small subunit p53R2 in human cancer cells
-
H.
Uramoto,
K.
Sugio,
T.
Oyama,
T.
Hanagiri,
K.
Yasumoto
(2006)
P53R2, p53 inducible ribonucleotide reductase gene, correlated with tumor progression of non-small cell lung cancer.
Anticancer research, 26 2A
-
Yan
Li,
C.
Jenkins,
M.
Nichols,
Y.
Xiong
(1994)
Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21.
Oncogene, 9 8
-
A.
Jordan,
P.
Reichard
(1998)
Ribonucleotide reductases.
Annual review of biochemistry, 67
-
B.
Friday,
A.
Adjei
(2008)
Advances in Targeting the Ras/Raf/MEK/Erk Mitogen-Activated Protein Kinase Cascade with MEK Inhibitors for Cancer Therapy
Clinical Cancer Research, 14
-
Takashi
Kimura,
S.
Takeda,
Y.
Sagiya,
M.
Gotoh,
Yusuke
Nakamura,
H.
Arakawa
(2003)
Impaired function of p53R2 in Rrm2b-null mice causes severe renal failure through attenuation of dNTP pools
Nature Genetics, 34
-
C.
Sherr,
James
Roberts
(1999)
CDK inhibitors: positive and negative regulators of G1-phase progression.
Genes & development, 13 12
-
A.
Ray,
A.
Shakya,
Deepak
Kumar,
B.
Ray
(2004)
Overexpression of Serum Amyloid A-Activating Factor 1 Inhibits Cell Proliferation by the Induction of Cyclin-Dependent Protein Kinase Inhibitor p21WAF-1/Cip-1/Sdi-1 Expression1
The Journal of Immunology, 172
-
Xiyong
Liu,
Bingsen
Zhou,
Lijun
Xue,
J.
Shih,
Kar-Yee
Tye,
Wei-Chou
Lin,
C.
Qi,
P.
Chu,
F.
Un,
W.
Wen,
Y.
Yen
(2006)
Metastasis-Suppressing Potential of Ribonucleotide Reductase Small Subunit p53R2 in Human Cancer Cells
Clinical Cancer Research, 12
-
A.
Subramanian,
P.
Tamayo,
V.
Mootha,
Sayan
Mukherjee,
B.
Ebert,
Michael
Gillette,
A.
Paulovich,
S.
Pomeroy,
T.
Golub,
E.
Lander,
J.
Mesirov
(2005)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
Proceedings of the National Academy of Sciences of the United States of America, 102
-
O.
Guittet,
Pelle
Håkansson,
N.
Voevodskaya,
S.
Fridd,
A.
Gräslund,
H.
Arakawa,
Yusuke
Nakamura,
L.
Thelander
(2001)
Mammalian p53R2 Protein Forms an Active Ribonucleotide Reductasein Vitro with the R1 Protein, Which Is Expressed Both in Resting Cells in Response to DNA Damage and in Proliferating Cells*
The Journal of Biological Chemistry, 276
-
W.
El-Deiry,
T.
Tokino,
V.
Velculescu,
D.
Levy,
R.
Parsons,
J.
Trent,
D.
Lin,
W.
Mercer,
K.
Kinzler,
B.
Vogelstein
(1993)
WAF1, a potential mediator of p53 tumor suppression
Cell, 75
-
(2008)
GammaH2AX and cancer
-
(2011)
Mol Cancer Ther Molecular Cancer Therapeutics
-
H.
Fan,
A.
Huang,
C.
Villegas,
James
Wright
(1997)
The R1 component of mammalian ribonucleotide reductase has malignancy-suppressing activity as demonstrated by gene transfer experiments.
Proceedings of the National Academy of Sciences of the United States of America, 94 24
-
H.
Devlin,
P.
Mack,
Rebekah
Burich,
P.
Gumerlock,
H.
Kung,
M.
Mudryj,
R.
White
(2008)
Impairment of the DNA Repair and Growth Arrest Pathways by p53R2 Silencing Enhances DNA Damage–Induced Apoptosis in a p53-Dependent Manner in Prostate Cancer Cells
Molecular Cancer Research, 6
-
Hiroshi
Tanaka,
H.
Arakawa,
Tatsuya
Yamaguchi,
K.
Shiraishi,
S.
Fukuda,
K.
Matsui,
Y.
Takei,
Yusuke
Nakamura
(2000)
A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage
Nature, 404
-
C.
Piao,
M.
Jin,
H.
Kim,
S.
Lee,
P.
Amatya,
J.
Hyun,
I.
Chang,
H.
You
(2009)
Ribonucleotide reductase small subunit p53R2 suppresses MEK–ERK activity by binding to ERK kinase 2
Oncogene, 28
-
T.
Yamaguchi,
K.
Matsuda,
Y.
Sagiya,
M.
Iwadate,
M.
Fujino,
Y.
Nakamura,
H.
Arakawa
(2001)
p53R2-dependent pathway for DNA synthesis in a p53-regulated cell cycle checkpoint.
Cancer research, 61 22
-
M.
Lebedeva,
J.
Eaton,
G.
Shadel
(2009)
Loss of p53 causes mitochondrial DNA depletion and altered mitochondrial reactive oxygen species homeostasis.
Biochimica et biophysica acta, 1787 5
-
J.
McCubrey,
Linda
Steelman,
W.
Chappell,
Stephen
Abrams,
E.
Wong,
F.
Chang,
B.
Lehmann,
D.
Terrian,
M.
Milella,
A.
Tafuri,
F.
Stivala,
M.
Libra,
J.
Basecke,
C.
Evangelisti,
A.
Martelli,
R.
Franklin
(2007)
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance.
Biochimica et biophysica acta, 1773 8
-
B.
Zhou,
Y.
Yen
(2001)
Characterization of the human ribonucleotide reductase M2 subunit gene; genomic structure and promoter analyses
Cytogenetic and Genome Research, 95
-
H.
Okumura,
S.
Natsugoe,
M.
Matsumoto,
Yuko
Mataki,
H.
Takatori,
S.
Ishigami,
S.
Takao,
T.
Aikou
(2005)
The predictive value of p53, p53R2, and p21 for the effect of chemoradiation therapy on oesophageal squamous cell carcinoma
British Journal of Cancer, 92
-
Pelle
Håkansson,
A.
Hofer,
L.
Thelander
(2006)
Regulation of Mammalian Ribonucleotide Reduction and dNTP Pools after DNA Damage and in Resting Cells*
Journal of Biological Chemistry, 281
-
Tsutomu
Yoshida,
S.
Haga,
Y.
Numata,
K.
Yamashita,
T.
Mikami,
T.
Ogawa,
T.
Ohkusa,
I.
Okayasu
(2006)
Disruption of the p53–p53r2 DNA repair system in ulcerative colitis contributes to colon tumorigenesis
International Journal of Cancer, 118
-
Bingsen
Zhou,
Xiyong
Liu,
X.
Mo,
Lijun
Xue,
Dana
Darwish,
W.
Qiu,
J.
Shih,
Edward
Hwu,
F.
Luh,
Y.
Yen
(2003)
The human ribonucleotide reductase subunit hRRM2 complements p53R2 in response to UV-induced DNA repair in cells with mutant p53.
Cancer research, 63 20
-
Bing-sen
Zhou,
P.
Tsai,
R.
Ker,
J.
Tsai,
R.
Ho,
Johnathan
Yu,
J.
Shih,
Y.
Yen
(1998)
Overexpression of transfected human ribonucleotide reductase M2 subunit in human cancer cells enhances their invasive potential
Clinical & Experimental Metastasis, 16
-
S.
Yanamoto,
Tsutomu
Iwamoto,
G.
Kawasaki,
I.
Yoshitomi,
N.
Baba,
A.
Mizuno
(2005)
Silencing of the p53R2 gene by RNA interference inhibits growth and enhances 5-fluorouracil sensitivity of oral cancer cells.
Cancer letters, 223 1